theory clinical_88_2
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  BRCAMutation :: "entity ⇒ bool"
  Have :: "entity ⇒ entity ⇒ bool"
  Olaparib :: "entity ⇒ bool"
  Talazoparib :: "entity ⇒ bool"
  PARPInhibitor :: "entity ⇒ bool"
  BRCAMutated :: "entity ⇒ bool"
  HER2Negative :: "entity ⇒ bool"
  AdvancedBC :: "entity ⇒ bool"
  MetastaticBC :: "entity ⇒ bool"
  LicensedForTreatment :: "entity ⇒ entity ⇒ bool"
  AppropriateFor :: "entity ⇒ entity ⇒ bool"

(* Explanation 1: Patient does not have BRCA mutation *)
axiomatization where
  explanation_1: "∀x y. Patient x ∧ BRCAMutation y ⟶ ¬Have x y"

(* Explanation 2: Olaparib and talazoparib are licensed PARP inhibitors for the treatment of patients with BRCA-mutated, HER-2-negative advanced or metastatic BC *)
axiomatization where
  explanation_2: "∀x y z. (Olaparib x ∨ Talazoparib x) ∧ PARPInhibitor x ∧ Patient y ∧ BRCAMutated y ∧ HER2Negative y ∧ (AdvancedBC y ∨ MetastaticBC y) ⟶ LicensedForTreatment x y"

(* Explanation 3: PARP inhibitors are only appropriate for patients with a BRCA mutation *)
axiomatization where
  explanation_3: "∀x y. PARPInhibitor x ∧ Patient y ∧ BRCAMutation y ⟶ AppropriateFor x y"

(* Explanation 4: If a patient does not have a BRCA mutation, then PARP inhibitors are not appropriate for them *)
axiomatization where
  explanation_4: "∀x y. (Patient x ∧ BRCAMutation y ⟶ ¬Have x y) ⟶ (∀z. PARPInhibitor z ⟶ ¬AppropriateFor z x)"

theorem hypothesis:
  assumes asm: "PARPInhibitor x ∧ Patient y"
  (* Hypothesis: PARP inhibitors not appropriate for this patient *)
  shows "∀x y. PARPInhibitor x ∧ Patient y ⟶ ¬AppropriateFor x y"
  using explanation_1 explanation_4 by blast
  

end
